Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancer

Carcinogenesis

Volumn 36, Issue 11, 2015, Pages 1341-1353

  Lawrenson, Kate ^ay   Iversen, Edwin S ^b   Tyrer, Jonathan ^c   Weber, Rachel Palmieri ^d   Concannon, Patrick ^e   Hazelett, Dennis J ^f   Li, Qiyuan ^g   Marks, Jeffrey R ^d   Berchuck, Andrew ^h   Lee, Janet M ^a   Aben, Katja K H ^i,j   Anton Culver, Hoda ^k   Antonenkova, Natalia ^l   Bandera, Elisa V ^m   Bean, Yukie ^n,o   Beckmann, Matthias W ^p   Bisogna, Maria ^q   Bjorge, Line ^r,s   Bogdanova, Natalia ^t   Brinton, Louise A ^u   Brooks Wilson, Angela ^v,w   Bruinsma, Fiona ^x   Butzow, Ralf ^y,z   Campbell, Ian G ^aa,ab,ac   Carty, Karen ^ad   Chang Claude, Jenny ^ae   Chenevix Trench, Georgia ^af   Chen, Ann ^ag   Chen, Zhihua ^ag   Cook, Linda S ^ah   Cramer, Daniel W ^ai,aj   Cunningham, Julie M ^ak   Cybulski, Cezary ^al   Plisiecka Halasa, Joanna ^am   Dennis, Joe ^an   Dicks, Ed ^an   Doherty, Jennifer A ^ao   Dörk, Thilo ^t   du Bois, Andreas ^e,aq   Eccles, Diana ^ar   Easton, Douglas T ^an   Edwards, Robert P ^ar,as   Eilber, Ursula ^ae   Ekici, Arif B ^p   Fasching, Peter A ^p,at   Fridley, Brooke L ^au   Gao, Yu Tang ^av   Gentry Maharaj, Aleksandra ^aw   Giles, Graham G ^x,ax   Glasspool, Rosalind ^ad   Goode, Ellen L ^ak   Goodman, Marc T ^ay   Gronwald, Jacek ^al   Harter, Philipp ^ap,aq   Hasmad, Hanis Nazihah ^az   Hein, Alexander ^p   Heitz, Florian ^ap,aq   Hildebrandt, Michelle A T ^ba   Hillemanns, Peter ^t   Hogdall, Estrid ^bb,bc   Hogdall, Claus ^bd   Hosono, Satoyo ^be   Jakubowska, Anna ^al   Paul, James ^ad   Jensen, Allan ^bf   Karlan, Beth Y ^ay   Kjaer, Susanne Kruger ^bd,bf   Kelemen, Linda E ^bg   Kellar, Melissa ^n,o   Kelley, Joseph L ^bh   Kiemeney, Lambertus A ^bi   Krakstad, Camilla ^r,s   Lambrechts, Diether ^bj,bk   Lambrechts, Sandrina ^bl   Le, Nhu D ^v   Lee, Alice W ^a   Cannioto, Rikki ^bm   Leminen, Arto ^y   Lester, Jenny ^ay   Levine, Douglas A ^q   Liang, Dong ^bn   Lissowska, Jolanta ^am   Lu, Karen ^ba   Lubinski, Jan ^al   Lundvall, Lene ^bd   Massuger, Leon F A G ^bi   Matsuo, Keitaro ^bo   McGuire, Valerie ^bp   McLaughlin, John R ^bq   Nevanlinna, Heli ^y   McNeish, Iain ^br   Menon, Usha ^aw   Modugno, Francesmary ^as,bh,bs,bt   Moysich, Kirsten B ^bm   Narod, Steven A ^bu   Nedergaard, Lotte ^bd   Ness, Roberta B ^bv   Noor Azmi, Mat Adenan ^bw   Odunsi, Kunle ^bm   Olson, Sara H ^q   Orlow, Irene ^q   Orsulic, Sandra ^ay   Pearce, Celeste L ^bx   Pejovic, Tanja ^n,o   Pelttari, Liisa M ^y   Permuth Wey, Jennifer ^ag   Phelan, Catherine M ^ag   Pike, Malcolm C ^b,q   Poole, Elizabeth M ^ai,by   Ramus, Susan J ^a   Risch, Harvey A ^bz   Rosen, Barry ^ca   Rossing, Mary Anne ^cb,cc   Rothstein, Joseph H ^bp   Rudolph, Anja ^ae   Runnebaum, Ingo B ^cd   Rzepecka, Iwona K ^al   Salvesen, Helga B ^r,s   Budzilowska, Agnieszka ^am   Sellers, Thomas A ^ag   Shu, Xiao Ou ^ce   Shvetsov, Yurii B ^cf   Siddiqui, Nadeem ^cg   Sieh, Weiva ^bp   Song, Honglin ^c   Southey, Melissa C ^ab   Sucheston, Lara ^bn   Tangen, Ingvild L ^r,s   Teo, Soo Hwang ^ba,bw   Terry, Kathryn L ^ai,aj   Thompson, Pamela J ^ay   Timorek, Agnieszka ^ch   Tworoger, Shelley S ^ai,by   Van Nieuwenhuysen, Els ^bl   Vergote, Ignace ^bl   Vierkant, Robert A ^ak   Wang Gohrke, Shan ^ci   Walsh, Christine ^ay   Wentzensen, Nicolas ^u   Whittemore, Alice S ^bp   Wicklund, Kristine G ^cc   Wilkens, Lynne R ^cf   Woo, Yin Ling ^bw   Wu, Xifeng ^ba   Wu, Anna H ^a   Yang, Hannah ^u   Zheng, Wei ^ce   Ziogas, Argyrios ^j   Coetzee, Gerhard A ^f   Freedman, Matthew L ^cj   Monteiro, Alvaro N A ^ag   Moes Sosnowska, Joanna ^am   Kupryjanczyk, Jolanta ^am   Pharoah, Paul D ^c   Gayther, Simon A ^ay   Schildkraut, Joellen M ^d,ck   more..

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b Duke University   (United States)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^g XIAMEN UNIVERSITY   (China)

^h DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ Comprehensive Cancer Center ^*  (Netherlands)

^j University of California Irvine ^*  (Netherlands)

^k UNIVERSITY OF CALIFORNIA   (United States)

^l Byelorussian Institute for Oncology and Medical Radiology Aleksandrov NN   (Belarus)

^m RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

ⁿ OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^o OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^p UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^q MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^r HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^s UNIVERSITY OF BERGEN   (Norway)

^t HANNOVER MEDICAL SCHOOL   (Germany)

^u NATIONAL CANCER INSTITUTE   (United States)

^v BRITISH COLUMBIA CANCER AGENCY   (Canada)

^w SIMON FRASER UNIVERSITY   (Canada)

^x CANCER EPIDEMIOLOGY CENTRE   (Australia)

^y UNIVERSITY OF HELSINKI   (Finland)

^z HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^aa PETER MACCALLUM CANCER CENTRE   (Australia)

^ab UNIVERSITY OF MELBOURNE   (Australia)

^ac UNIVERSITY OF MELBOURNE   (Australia)

^ad BEATSON WEST OF SCOTLAND CANCER CENTRE   (United Kingdom)

^ae GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^af QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^ag H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^ah UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^ai HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^aj HARVARD MEDICAL SCHOOL   (United States)

^ak MAYO CLINIC   (United States)

^al POMERANIAN MEDICAL UNIVERSITY   (Poland)

^am INSTITUTE OF ONCOLOGY   (Poland)

^an UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^ao DARTMOUTH MEDICAL SCHOOL   (United States)

^ap KLINIKEN ESSEN MITTE   (Germany)

^aq DR HORST SCHMIDT KLINIKEN   (Germany)

^ar PRINCESS ANNE HOSPITAL   (United Kingdom)

^as UNIVERSITY OF PITTSBURGH   (United States)

^at UNIVERSITY OF CALIFORNIA   (United States)

^au UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^av SHANGHAI CANCER INSTITUTE   (China)

^aw UNIVERSITY COLLEGE LONDON   (United Kingdom)

^ax UNIVERSITY OF MELBOURNE   (Australia)

^ay CEDARS SINAI MEDICAL CENTER   (United States)

^az CANCER RESEARCH INITIATIVES FOUNDATION   (Malaysia)

^ba UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^bb INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^bc GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^bd University of Copenhagen   (Denmark)

^be AICHI CANCER CENTER HOSPITAL   (Japan)

^bf DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^bg MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^bh UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^bi RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^bj DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^bk UNIVERSITY OF LEUVEN   (Belgium)

^bl UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^bm ROSWELL PARK CANCER INSTITUTE   (United States)

^bn TEXAS SOUTHERN UNIVERSITY   (United States)

^bo KYUSHU UNIVERSITY   (Japan)

^bp STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^bq MOUNT SINAI HOSPITAL   (Canada)

^br UNIVERSITY OF GLASGOW   (United Kingdom)

^bs UNIVERSITY OF PITTSBURGH   (United States)

^bt UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^bu WOMEN S COLLEGE HOSPITAL   (Canada)

^bv UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^bw UNIVERSITY MALAYA MEDICAL CENTRE   (Malaysia)

^bx UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^by CHANNING LABORATORY   (United States)

^bz YALE UNIVERSITY   (United States)

^ca UNIVERSITY OF TORONTO   (Canada)

^cb USA   (United States)

^cc UNIVERSITY OF WASHINGTON   (United States)

^cd JENA UNIVERSITY HOSPITAL   (Germany)

^ce VANDERBILT INGRAM CANCER CENTER   (United States)

^cf UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^cg GLASGOW ROYAL INFIRMARY   (United Kingdom)

^ch Brodnowski Hospital Warsaw   (Poland)

^ci UNIVERSITY OF ULM   (Germany)

^cj DANA FARBER CANCER INSTITUTE   (United States)

^ck DUKE CANCER INSTITUTE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CAMP RESPONSIVE ELEMENT BINDING PROTEIN 5; CHECKPOINT KINASE 2; COILED COIL DOMAIN CONTAINING 117; EXONUCLEASE 1; FANCONI ANEMIA GROUP A PROTEIN; HSCB MITOCHONDRIAL IRON SULFUR CLUSTER COCHAPERONE; MESSENGER RNA; TETRATRICOPEPTIDE REPEAT DOMAIN 28; TRANSCRIPTION FACTOR E2F2; TRANSCRIPTION FACTOR E2F4; TUMOR MARKER; UNCLASSIFIED DRUG; X BOX BINDING PROTEIN 1; ZINC AND RING FINGER 3; CHEK2 PROTEIN, HUMAN;

ARTICLE; BINDING SITE; CANCER RISK; CAOV-3 CELL LINE; CELL LINE BY CELL TYPE; CHEK2 GENE; CHROMATIN IMMUNOPRECIPITATION SEQUENCING; COMMON GENETIC VARIANTS; CONTROLLED STUDY; DNA REPAIR GENES; EXPRESSION QUANTITATIVE TRAIT LOCUS; FALLOPIAN TUBE; FALLOPIAN TUBE TISSUE; FEMALE; FT246 CELL LINE; FT33 CELL LINE; GENE; GENE EXPRESSION; GENE LOCUS; GENETIC VARIABILITY; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; GENOTYPING; HUMAN; HUMAN CELL; HUMAN TISSUE; INDEL MUTATION; INVASIVE CARCINOMA; IOE11 CELL LINE; IOE4 CELL LINE; OVARY CARCINOMA; POLYMERASE CHAIN REACTION; REGULATORY SEQUENCE; RISK ASSOCIATED VARIANTS; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR GENE; UWB1.289 CELL LINE; CASE CONTROL STUDY; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS; NEOPLASM; OVARY TUMOR; QUANTITATIVE TRAIT LOCUS; RISK FACTOR;

CASE-CONTROL STUDIES; CHECKPOINT KINASE 2; FEMALE; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; QUANTITATIVE TRAIT LOCI; RISK FACTORS;

EID: 85016071187     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgv138     Document Type: Article

References (51)

1. American Cancer Society. (2012) Cancer Facts & Figures 2012. American Cancer Society, Atlanta.
2. Murdoch, W.J. et al. (2001) Ovulation-induced DNA damage in ovarian surface epithelial cells of ewes: prospective regulatory mechanisms of repair/survival and apoptosis. Biol. Reprod., 65, 1417–1424.
3. Bahar-Shany, K. et al. (2014) Exposure of fallopian tube epithelium to follicular fluid mimics carcinogenic changes in precursor lesions of serous papillary carcinoma. Gynecol. Oncol., 132, 322–327.
4. Schildkraut, J.M. et al. (1997) Relationship between lifetime ovulatory cycles and overexpression of mutant p53 in epithelial ovarian cancer. J. Natl. Cancer Inst., 89, 932–938.
5. Moynahan, M.E. et al. (1999) Brca1 controls homology-directed DNA repair. Mol. Cell, 4, 511–518.
6. Wooster, R. et al. (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature, 378, 789–792.
7. Futreal, P.A. et al. (1994) BRCA1 mutations in primary breast and ovarian carcinomas. Science, 266, 120–122.
8. Miki, Y. et al. (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science, 266, 66–71.
9. Song, H. et al. (2014) The contribution of deleterious germline mutations in BRCA1, BRCA2 and the mismatch repair genes to ovarian cancer in the population. Hum. Mol. Genet., 23, 4703–4709.
10. Meindl, A. et al. (2010) Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene. Nat. Genet., 42, 410–414.
11. Loveday, C. et al. (2011) Germline mutations in RAD51D confer susceptibility to ovarian cancer. Nat. Genet., 43, 879–882.
12. Rafnar, T. et al. (2011) Mutations in BRIP1 confer high risk of ovarian cancer. Nat. Genet., 43, 1104–1107.
13. Song, H. et al. (2009) A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2. Nat. Genet., 41, 996–1000.
14. Goode, E.L. et al. (2010) A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. Nat. Genet., 42, 874–879.
15. Bolton, K.L. et al. (2010) Common variants at 19p13 are associated with susceptibility to ovarian cancer. Nat. Genet., 42, 880–884.
16. Pharoah, P.D. et al. (2013) GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. Nat. Genet., 45, 362–370.
17. Permuth-Wey, J. et al. (2013) Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31. Nat. Commun., 4, 16–27.
18. Bojesen, S.E. et al. (2013) Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat. Genet., 45, 371–384.
19. Shen, H. et al. (2013) Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer. Nat. Commun., 4, 16–28.
20. Chen, K. et al. (2014) Genome-wide association study identifies new susceptibility loci for epithelial ovarian cancer in Han Chinese women. Nat. Commun., 5, 4682.
21. Kuchenbaecker, K.B. et al. (2015) Identification of six new susceptibility loci for invasive epithelial ovarian cancer. Nat. Genet., 47, 164–171.
22. Michailidou, K. et al. (2013) Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat. Genet., 45, 353–361.
23. Lee, J.S. et al. (2000) hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response. Nature, 404, 201–204.
24. Consortium, C.B.C.C.-C. (2004) CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies. Am. J. Hum. Genet., 74, 1175–1182.
25. Walsh, T. et al. (2011) Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing. Proc. Natl. Acad. Sci. USA, 108, 18032–18037.
26. Schildkraut, J.M. et al. (2010) Association between DNA damage response and repair genes and risk of invasive serous ovarian cancer. PLoS One, 5, e10061.
27. Wood, R.D. et al. (2005) Human DNA repair genes, 2005. Mutat. Res., 577, 275–283.
28. Howie, B.N. et al. (2009) A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet., 5, e1000529.
29. Westra, H.J. et al. (2013) Systematic identification of trans eQTLs as putative drivers of known disease associations. Nat. Genet., 45, 1238–1243.
30. Karst, A.M. et al. (2012) Primary culture and immortalization of human fallopian tube secretory epithelial cells. Nat. Protoc., 7, 1755–1764.
31. DelloRusso, C. et al. (2007) Functional characterization of a novel BRCA1-null ovarian cancer cell line in response to ionizing radiation. Mol. Cancer Res., 5, 35–45.
32. Hazelett, D.J. et al. (2014) Comprehensive functional annotation of 77 prostate cancer risk loci. PLoS Genet., 10, e1004–102.
33. Lawrenson, K. et al. (2009) In vitro three-dimensional modelling of human ovarian surface epithelial cells. Cell Prolif., 42, 385–393.
34. Li, N.F. et al. (2004) A modified medium that significantly improves the growth of human normal ovarian surface epithelial (OSE) cells in vitro. Lab. Invest., 84, 923–931.
35. Li, Q. et al. (2013) Integrative eQTL-based analyses reveal the biology of breast cancer risk loci. Cell, 152, 633–641.
36. Wang, J. et al. (2013) Factorbook.org: a Wiki-based database for transcription factor-binding data generated by the ENCODE consortium. Nucleic Acids Res., 41, D171–D176.
37. Coetzee, S.G. et al. (2015) Cell type specific enrichment of risk associated regulatory elements at ovarian cancer susceptibility loci. Hum. Mol. Genet, 24, 3595–3607.
38. Kulakovskiy, I.V. et al. (2013) HOCOMOCO: a comprehensive collection of human transcription factor binding sites models. Nucleic Acids Res., 41, D195–D202.
39. Izumiyama, T. et al. (2012) A novel big protein TPRBK possessing 25 units of TPR motif is essential for the progress of mitosis and cytokinesis. Gene, 511, 202–217.
40. Uhrigshardt, H. et al. (2010) Characterization of the human HSC20, an unusual DnaJ type III protein, involved in iron-sulfur cluster biogenesis. Hum. Mol. Genet., 19, 3816–3834.
41. Hao, H.X. et al. (2012) ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner. Nature, 485, 195–200.
42. Forbes, S.A. et al. (2014) COSMIC: exploring the world’s knowledge of somatic mutations in human cancer. Nucleic Acids Res, 43, D805–D811.
43. Lawrenson, K. et al. (2011) Modelling genetic and clinical heterogeneity in epithelial ovarian cancers. Carcinogenesis, 32, 1540–1549.
44. Eeles, R.A. et al. (2013) Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nat. Genet., 45, 385–391.
45. Deloukas, P. et al. (2013) Large-scale association analysis identifies new risk loci for coronary artery disease. Nat. Genet., 45, 25–33.
46. Cheng, J.C. et al. (2013) Egr-1 mediates epidermal growth factor-induced downregulation of E-cadherin expression via Slug in human ovarian cancer cells. Oncogene, 32, 1041–1049.
47. Hohenstein, P. et al. (2006) The many facets of the Wilms' tumour gene, WT1. Hum. Mol. Genet., 15, R196–R201.
48. Network, C.G.A.R. (2011) Integrated genomic analyses of ovarian carcinoma. Nature, 474, 609–615.
49. Mullan, P.B. et al. (2006) The role of BRCA1 in transcriptional regulation and cell cycle control. Oncogene, 25, 5854–5863.
50. Le Calvez-Kelm, F. et al. (2011) Rare, evolutionarily unlikely missense substitutions in CHEK2 contribute to breast cancer susceptibility: results from a breast cancer family registry case-control mutation-screening study. Breast Cancer Res., 13, R6.
51. Pomerantz, M.M. et al. (2010) Analysis of the 10q11 cancer risk locus implicates MSMB and NCOA4 in human prostate tumorigenesis. PLoS Genet., 6, e1001204.